MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarson, K. E.
Right arrow Articles by Krause, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCarson, K. E.
Right arrow Articles by Krause, J. E.

The neurokinin-1 receptor antagonist LY306,740 blocks nociception- induced increases in dorsal horn neurokinin-1 receptor gene expression

KE McCarson and JE Krause

Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Dilute formalin injected into the rat hindpaw as a nociceptive stimulus increases neurokinin-1 receptor (NK-1R) mRNA levels in the dorsal horn of the spinal cord. Increased NK-1R mRNA levels could result from increased mRNA stability or an increased rate of NK-1R mRNA transcription. In this study, RNA samples prepared from the spinal cords of rats receiving an injection of formalin into the right hindpaw were assayed for NK-1R mRNA with the use of solution hybridization- nuclease protection assays. The mature and incompletely spliced NK-1R- encoding RNAs protected by endogenous rat RNAs were characterized by the use of NK-1R plasmid constructs containing intron sequences. NK-1R pre-mRNA species were enriched in the nuclear fractions of spinal cord samples, and in the steady state, total molar amounts of NK-1R pre- mRNAs were 2-fold greater than those of mature NK-1R mRNA. In formalin- treated animals, the temporal pattern of peak pre-mRNA levels compared with mature mRNA indicated that chemogenic nociception either activates transcription of the NK-1R gene or decreases the rate of pre-mRNA splicing. In the ipsilateral lumbar dorsal hom, NK-1R mRNA levels were significantly increased at 2 and 6 hr after formalin injection. Levels of the NK-1R pre-mRNA containing both introns A and B were significantly increased 1 hr after formalin treatment, and levels of NK- 1R pre-mRNAs containing intron A were significantly elevated at 2 hr after formalin treatment. Pretreatment of rats with the selective NK-1R antagonist LY306,740 was used to determine the role of NK-1R activation in the regulation of nociception-induced NK-1R mRNA levels. Rats were pretreated with either LY306,740 or LY307,679 (an inactive enantiomer) before injection of formalin into the right hindpaw. Pretreatment with LY306,740 (but not LY307,679) completely blocked the formalin-induced increase in dorsal horn NK-1R mRNA levels and significantly reduced formalin-induced behavioral activity. Thus, activation of the NK-1R during nociception increases dorsal horn NK-1R mRNA levels through activation of transcriptional or splicing mechanisms. The stimulation of NK-1R gene expression by activation of the NK-1R provides a homologous mechanism for altering the sensitivity of dorsal horn cells to substance P, potentially via the actions of second messengers, which presumably results in the maintenance of proper sensory information processing during long term nociception.

Volume 50, Issue 5, pp. 1189-1199, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
V. Duric and K. E. McCarson
Effects of Analgesic or Antidepressant Drugs on Pain- or Stress-Evoked Hippocampal and Spinal Neurokinin-1 Receptor and Brain-Derived Neurotrophic Factor Gene Expression in the Rat
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1235 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. Winter and K. E. McCarson
G-Protein Activation by Neurokinin-1 Receptors Is Dynamically Regulated during Persistent Nociception
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. J. P. Fontan, D. N. Cortright, J. E. Krause, C. R. Velloff, V. V. Karpitskyi, T. W. Carver Jr., S. D. Shapiro, and B. N. Mora
Substance P and neurokinin-1 receptor expression by intrinsic airway neurons in the rat
Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L344 - L355.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Honore, P. M. Menning, S. D. Rogers, M. L. Nichols, A. I. Basbaum, J.-M. Besson, and P. W. Mantyh
Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States
J. Neurosci., September 1, 1999; 19(17): 7670 - 7678.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Inoue, M. Kobayashi, S. Kozaki, A. Zimmer, and H. Ueda
Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice
PNAS, September 1, 1998; 95(18): 10949 - 10953.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics